Potential Use of Biological Proteins for Liver Failure Therapy
AbstractBiological proteins have unlimited potential for use as pharmaceutical products due to their various biological activities, which include non-toxicity, biocompatibility, and biodegradability. Recent scientific advances allow for the development of novel innovative protein-based products that draw on the quality of their innate biological activities. Some of them hold promising potential for novel therapeutic agents/devices for addressing hepatic diseases such as hepatitis, fibrosis, and hepatocarcinomas. This review attempts to provide an overview of the development of protein-based products that take advantage of their biological activity for medication, and discusses possibilities for the therapeutic potential of protein-based products produced through different approaches to specifically target the liver (or hepatic cells: hepatocytes, hepatic stellate cells, liver sinusoidal endothelial cells, and Kupffer cells) in the treatment of hepatic diseases. View Full-Text
Share & Cite This Article
Taguchi, K.; Yamasaki, K.; Seo, H.; Otagiri, M. Potential Use of Biological Proteins for Liver Failure Therapy. Pharmaceutics 2015, 7, 255-274.
Taguchi K, Yamasaki K, Seo H, Otagiri M. Potential Use of Biological Proteins for Liver Failure Therapy. Pharmaceutics. 2015; 7(3):255-274.Chicago/Turabian Style
Taguchi, Kazuaki; Yamasaki, Keishi; Seo, Hakaru; Otagiri, Masaki. 2015. "Potential Use of Biological Proteins for Liver Failure Therapy." Pharmaceutics 7, no. 3: 255-274.